Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival.

European journal of histochemistry : EJH - 1 Jan 1998

Sessa F, Bonato M, Bisoni D, Ranzani G N, Capella C

Abstract excerpt

We investigated a series of clinically well documented pancreatic ductal adenocarcinomas for the presence of molecular alterations of the p53 and Ki-ras genes and their correlations with p53 nuclear immunohistochemical expression. The results were evaluated in comparison with cellular expression, by ductal cancer cells, of gastric (PGII) and intestinal (CAR-5) antigens and with several clinicopathologic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Carcinoma, Ductal, Breast

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, p53

Share to Genes, ras

Share to Immunohistochemistry

Share to Pancreatic Neoplasms

Share to Survivors

Source

Identifiers

PMID: 10076772

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ki-ras and p53 gene mutations in pancreatic ductal carcinoma: a relationship with tumor phenotype and survival.PMID 10076772Read ↗

Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

p53 protein overexpression and K-ras codon 12 mutation in pancreatic ductal carcinoma: correlation with histologic factors.Semantic proximity Read ↗

p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.Semantic proximity Read ↗

K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.Semantic proximity Read ↗

Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.Semantic proximity Read ↗

Genetic basis of cancer of the pancreas: diagnostic and therapeutic applications.Semantic proximity Read ↗

Prevalence and clinical significance of combined K-ras mutation and p53 aberration in pancreatic adenocarcinoma.Semantic proximity Read ↗

KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators.Semantic proximity Read ↗

Pancreatic adenocarcinomas frequently show p53 gene mutations.Semantic proximity Read ↗

K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.